Drug Profile
Research programme: bispecific antibody therapeutics - Pandion Therapeutics
Alternative Names: CD39 effector; Kidney tether; Pancreas tether; Skin tetherLatest Information Update: 28 Feb 2022
Price :
$50
*
At a glance
- Originator Pandion Therapeutics
- Class Anti-inflammatories; Antihyperglycaemics; Bispecific antibodies; Hepatoprotectants; Skin disorder therapies; Urologics
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Inflammatory bowel diseases; Kidney disorders; Liver disorders; Skin disorders; Type 1 diabetes mellitus
Most Recent Events
- 28 Feb 2022 No recent reports of development identified for research development in Inflammatory-bowel-diseases in USA (Parenteral)
- 28 Feb 2022 No recent reports of development identified for research development in Kidney-disorders in USA (Parenteral)
- 28 Feb 2022 No recent reports of development identified for research development in Liver-disorders in USA (Parenteral)